Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

GHRP-6 Dosing Protocol: 5 mg Vial — Full Cycle GH

GHRP-6 5 mg vial: 2 mg/mL, 200–300 μg (10–15 units) 2–3x daily. Hunger response, cortisol monitoring, CJC-1295 synergy. Reviewed Feb 2026. Reviewed Feb 2026.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

GHRP-6 Dosing Protocol: 5 mg Vial — Full Cycle Dosing Schedule & Supplies

Complete GHRP-6 dosing protocol using the 5 mg vial, covering full 4–12 week GH secretagogue cycles with supplies checklist.

Quickstart highlights

GHRP-6 was among the first synthetic GHRPs studied in humans (Bowers et al., 1984).

Concentration: 2 mg/mL (5 mg vial + 2.5 mL bacteriostatic water).

At 2 mg/mL: 200 μg = 10 units, 300 μg = 15 units per injection.

GHRP-6 causes significant hunger within 30 minutes — the strongest appetite effect among GHRPs.

At 300 μg 3x daily, one 5 mg vial lasts ~5–6 days; plan 15+ vials for a 12-week cycle.

Combine with CJC-1295 No DAC for 2–4x greater GH output.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

1-4

200

10

2x daily (fasted)

200 μg — 10 units; 5 mg vial provides 25 doses (~12 days at 2x daily)

5-12

300

15

2–3x daily (fasted)

300 μg — 15 units; 17 doses per vial (~8 days at 2x daily, 5–6 days at 3x daily)

Your free GHRP-6 tracker

Dose reminders

Injection logging

Cycle progress

Reconstitution steps

Draw 2.5 mL bacteriostatic water; inject slowly down vial wall.

Swirl gently until dissolved; do not shake.

Final concentration: 2 mg/mL. Label with date; refrigerate at 2–8 °C. Use within 28 days.

Supplies needed

4-week plan

1 vial

28 syringes

3 mL bac water

28 alcohol swabs

8-week plan

3 vials

56 syringes

8 mL bac water

56 alcohol swabs

12-week plan

5 vials

84 syringes

13 mL bac water

84 alcohol swabs

Protocol overview & cycle notes

Stimulate robust GH secretion and leverage GHRP-6's appetite-stimulating properties using the 5 mg vial for full 4–12 week cycles, particularly suitable for patients seeking concurrent GH-mediated anabolism and appetite enhancement.

Cycle length: 12 weeks on.

Off-cycle: 4–6 weeks off after every 12-week cycle; monitor morning cortisol.

Storage & handling

Injection & tracking tips

Inject immediately before planned meals to leverage GHRP-6's appetite-stimulating effect for caloric intake.

Do not inject GHRP-6 if already full — food at injection time suppresses GH response by up to 50%.

Combine with CJC-1295 No DAC for synergistic GH release; inject both from the same syringe or adjacent sites simultaneously.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

Track appetite and meal caloric intake for the first 4 weeks — GHRP-6 is sometimes used to increase caloric intake in underweight individuals.

Measure IGF-1 at baseline and 6 weeks.

Monitor morning cortisol monthly; GHRP-6 at 300 μg can elevate cortisol by 20–40%.

How this works & references

Sources

Source: Bowers CY et al. — First synthetic GH-releasing peptide in humans. J Clin Endocrinol Metab. 1984

Growth hormone secretagogues. Clinical experience and therapeutic potential. Laron Z et al. — Drugs — 1995

Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. Jaffe CA et al. — J Clin Endocrinol Metab — 1993

Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat. Conley LK et al. — Neuroendocrinology — 1995

Frequently asked questions

Related protocols

KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide

KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.

GLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide

GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Connected topics

Follow this recovery question